EXAS Value Score

3

24

15

Average Growth
  • AI analysis rates EXAS  with a lower value score of 2.
  • It is mainly due to  unstable operating cash flow, along with lower ROE.
  • Over the past 3 months, EXAS has maintained an average value rating of 2.8, close to the rating of 2.8 over the past 3 years, indicating low growth opportunities for enterprise value.
  • Compared to all stocks in the Health Care sector, EXAS has a lower value rating.

EXAS Value Reference Factors

The Value score is derived from various data and factor information, integrated through AI algorithms. The following factors are part of the evaluation used by AI value scores.

Update to 2023/07/13 (Weekly Update)

EXAS Financial Forecast

Unit : USD

Update to 2024/5/23 (Quarterly Update)

EXAS Earnings Table

Unit : USD

QTREPSEPS YoYEPS Surprise %SalesSales YoYSales Surprise %NPM
Current
-0.6
-42.9%
-27.4%
637.52M
5.8%
1.6%
-17.3%
2023Q4
-0.27
62.5%
41.2%
646.89M
17%
1.3%
-7.7%
2023Q3
0
100%
100%
628.34M
20.1%
1.9%
0.1%
2023Q2
-0.45
45.8%
11.7%
622.09M
19.3%
3.7%
-13%
2023Q1
-0.42
59.6%
44.2%
602.45M
23.8%
10.9%
-12.3%

Update to 2024/5/23 (Quarterly Update)

EXAS Historical Value Score

You can use historical scores of 3 or above to observe potential performance and make investment decisions.

EXAS Value Strategy Backtest

The following backtest is based on specified rules since 2007. Price chart shows buy/sell time, cumulative returns, and backtesting statistics.

Entry
Exit

The Backtest Result of EXAS from 2007/01 till Now

2098.94%
Cumulative Return
19.78%
Annual Return
64.36%
Volatility
0.31
Sharpe Ratio

Statistics data for entering at or above a Value score of 4 and exiting at or below a Value score of 2 from January, 2007 to May, 2024. (Total Trades: 4)

EXASSectorUS Overall Market
Wining Rate75%46%56%
Avg Return195.4%47%57%
Avg Profit273.8%159.7%130%
Avg Loss-39.6%-48%-35.6%
Avg Risk-Reward Ratio691.8%332.7%364.8%

Update to 2024/5/23 (Daily Update)

Top 10 High Relevance to EXAS Value Score